Key facts
- Override’s last known valuation is $23.5M (Jun 2025).
- It has raised $6.3M; the latest was Seed Round ($6.3M) in Jun 2025.
- Notable investors include SignalFire, Martin Ventures, Corewell Health Ventures, 7wire Ventures, Confluent Health — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Override
- ·The full record, as it builds
Funding rounds
No funding rounds for Override are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Override
Operator of a digital healthcare platform intended to provide comprehensive care to control chronic suffering. The company's platform offers online access to pain specialists in pain medicine, physical therapy, psychology, and coaching to create personalized treatment plans, enabling patients living with chronic pain to manage their condition, reduce symptoms, and improve their quality of life.
- Sector
- Healthcare
- HQ
- Middletown, DE, United States
- Founded
- 2021
- Employees
- 44
- Website
- override.health/
- Ownership
- Privately Held (backing)
Override doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Override shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Override in its N-PORT filings yet. We sweep new filings monthly.